Tissue TransplantationComplicityFetal Tissue TransplantationPersonhoodDirected Tissue DonationLifeBrain Tissue TransplantationBeginning of Human LifeTissue and Organ ProcurementAborted FetusOrgan SpecificityOrgan TransplantationKidneyKidney TransplantationHospitals, StateLiver TransplantationHand TransplantationTransplantation, HomologousTransplantationTissue DonorsTransplantation, HeterotopicGraft SurvivalLiverTransplantation ImmunologyBone Marrow TransplantationHeart TransplantationHematopoietic Stem Cell TransplantationLung TransplantationPregnant WomenPrimary Ovarian InsufficiencySkin TransplantationEthics, MedicalGraft RejectionTransplantation, AutologousCryopreservationStem Cell TransplantationImmunosuppressive AgentsTransplantation ConditioningTransplantsIslets of Langerhans TransplantationOvaryLiving DonorsPancreas TransplantationTreatment OutcomeCell TransplantationTransplantation ChimeraGraft vs Host DiseaseHeart-Lung TransplantationTime FactorsImmunosuppressionTransplantation, IsogeneicRetrospective StudiesPostoperative ComplicationsWaiting ListsHistocompatibility TestingLiver FailureTacrolimusCord Blood Stem Cell TransplantationCyclosporineTransplantation ToleranceCadaverPeripheral Blood Stem Cell TransplantationRecurrenceHistocompatibilityFollow-Up StudiesCytomegalovirus InfectionsHematologic NeoplasmsKidney Failure, ChronicSurvival AnalysisSurvival RateMycophenolic AcidCorneal TransplantationWhole-Body IrradiationTransplantation, HeterologousLiver DiseasesRisk FactorsBronchiolitis ObliteransMesenchymal Stem Cell TransplantationHLA AntigensFacial TransplantationAntilymphocyte SerumTissue and Organ HarvestingBrain DeathImmunocompromised HostLeukemiaAcute DiseaseEnd Stage Liver DiseaseBusulfanPostoperative PeriodProspective StudiesMice, Inbred C57BLBiopsyDonor SelectionPrognosisBlood Group IncompatibilityCombined Modality TherapyAnemia, AplasticPatient SelectionRats, Inbred LewIsoantibodies